Validation Study of RETINA-AI Galaxy™ v2.0, an Automated Diabetic Retinopathy Screening Device

Clinical trial NCT05368623 · COMPLETED

Trial details

NCT number: NCT05368623
Sponsor: RETINA-AI Health, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Diabetes Diabetic Retinopathy Diabetic Macular Edema Diabetic Eye Problems

Start date: 2022-11-03
Primary completion: 2023-03-31
Enrollment: 1100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.